PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 69 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $20,000 | +900.0% | 64,560 | +1449.3% | 0.00% | – |
| Q3 2016 | $2,000 | -89.5% | 4,167 | -91.8% | 0.00% | -100.0% |
| Q2 2016 | $19,000 | +18.8% | 51,093 | +34.6% | 0.00% | 0.0% |
| Q1 2016 | $16,000 | +45.5% | 37,955 | +303.9% | 0.00% | 0.0% |
| Q4 2015 | $11,000 | +57.1% | 9,398 | +84.6% | 0.00% | +100.0% |
| Q2 2015 | $7,000 | +40.0% | 5,090 | +41.9% | 0.00% | 0.0% |
| Q1 2015 | $5,000 | -95.2% | 3,588 | -95.3% | 0.00% | -91.7% |
| Q3 2014 | $104,000 | +333.3% | 76,914 | +492.9% | 0.01% | +300.0% |
| Q1 2014 | $24,000 | +100.0% | 12,973 | +36.2% | 0.00% | +200.0% |
| Q2 2013 | $12,000 | – | 9,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |